Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Safety and Immunogenicity of Zoster Vaccine Live in Patients on Chronic Corticosteroids
2006-003651-20Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2007
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of zoster vaccine, live in herpes zoster (HZ), sponsored by Merck & Co. Primary endpoint: Generalized vaccine-strain VZV-like rashes (primary). Started Jan 2007; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2006-003651-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003651-20.